Jefferies downgraded MoonLake Immunotherapeutics (MLTX) to Hold from Buy with a price target of $8, down from $65.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLTX:
- Morning Wrap-Up: Monday’s Biggest Stock Market Stories!
- Leerink sees greater opportunity for Oruka’s ORKA-002 after MoonLake news
- Oruka Therapeutics jumps 28% after MoonLake data miss
- EA acquired in go-private deal for $55B, Carnival reports Q3 beat: Morning Buzz
- MoonLake Immunotherapeutics falls -89.4%